Balance Sheet

4.7B

Assets

1.3B

Liabilities

3.4B

Equity

Current Assets	2.2B
Cash & Short-Term Investments	1.2B
Receivables	568.2m
Other Current Assets	483.6m
Non-Current Assets	2.5B
Long-Term Investments	804.1m
PP&E	921.5m
Intangibles	656.7m
Other Non-Current Assets	83m

Current Liabilities	770.1m
Accounts Payable	710.2m
Other Current Liabilities	60m
Non-Current Liabilities	556m
Long-Term Debt	561.3m
Other Non-Current Liabilities	-5.3m

Currency: CNY

	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	256	255	645	452	353	299	972	1 119	834	979
Cash	256	255	645	452	353	299	972	1 119	834	979
Short-Term Investments	0	0	0	0	5	50	171	357	0	200
Total Receivables	77	96	112	102	108	100	145	162	216	568
Accounts Receivables	65	71	83	74	91	73	107	110	137	105
Other Receivables	12	25	28	28	16	27	38	52	78	463
Inventory	31	38	40	39	71	99	100	129	241	484
Other Current Assets	14	12	15	14	42	58	158	69	106	0
Total Current Assets	388	401	812	607	578	606	1 545	1 837	1 397	2 231
PP&E Net	61	272	348	330	353	452	500	744	816	921
PP&E Gross	61	272	348	330	353	452	500	744	816	0
Accumulated Depreciation	32	35	39	50	69	98	127	158	179	0
Intangible Assets	53	78	111	152	203	259	305	365	442	657
Note Receivable	0	0	6	0	0	0	0	0	0	0
Long-Term Investments	3	3	3	130	308	334	569	191	972	804
Other Long-Term Assets	61	48	50	51	90	122	36	47	63	83
Total Assets	566 N/A	802 +42%	1 330 +66%	1 270 -5%	1 531 +21%	1 772 +16%	2 955 +67%	3 184 +8%	3 690 +16%	4 696 +27%
Liabilities
Accounts Payable	6	24	32	21	19	10	19	31	63	710
Accrued Liabilities	31	45	60	65	91	118	144	237	291	0
Short-Term Debt	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	0	0	20	0	2	125	181	11	5	6
Other Current Liabilities	29	52	109	70	96	89	150	203	226	54
Total Current Liabilities	66	121	221	156	208	341	494	482	585	770
Long-Term Debt	78	145	180	0	22	228	5	140	147	561
Minority Interest	5	0	3	3	3	10	18	27	21	46
Other Liabilities	266	355	58	57	57	41	98	32	37	41
Total Liabilities	415 N/A	622 +50%	462 -26%	217 -53%	291 +34%	620 +113%	614 -1%	680 +11%	790 +16%	1 326 +68%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0
Retained Earnings	103	74	98	267	452	373	730	879	1 077	3 370
Additional Paid In Capital	252	252	768	785	798	779	1 608	1 621	1 628	0
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	191	0
Treasury Stock	0	0	0	0	10	0	0	0	0	0
Other Equity	2	2	1	0	1	1	2	4	4	0
Total Equity	151 N/A	180 +19%	868 +381%	1 053 +21%	1 240 +18%	1 152 -7%	2 340 +103%	2 504 +7%	2 900 +16%	3 370 +16%
Total Liabilities & Equity	566 N/A	802 +42%	1 330 +66%	1 270 -5%	1 531 +21%	1 772 +16%	2 955 +67%	3 184 +8%	3 690 +16%	4 696 +27%
Shares Outstanding
Common Shares Outstanding	4 000	4 000	4 321	4 329	4 329	4 320	4 627	4 630	4 630	4 630

Income Statement Balance Sheet Cash Flow Statement

LifeTech Scientific Corp
HKEX:1302

Balance Sheet

Balance Sheet Decomposition
LifeTech Scientific Corp

Balance Sheet
LifeTech Scientific Corp

See Also

Company

Help

Tools

Stocks

LifeTech Scientific Corp HKEX:1302

Balance Sheet

Balance Sheet Decomposition LifeTech Scientific Corp

Balance Sheet LifeTech Scientific Corp

See Also

Company

Help

Tools

Stocks

LifeTech Scientific Corp
HKEX:1302

Balance Sheet Decomposition
LifeTech Scientific Corp

Balance Sheet
LifeTech Scientific Corp